@misc{indiciaee8cb89533b53,
  title = {Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19},
  author = {Sasaki, M. and Tabata, K. and Kishimoto, M. and Itakura, Y. and Kobayashi, H. and Ariizumi, T. and Uemura, K. and Toba, S. and Kusakabe, S. and Maruyama, Y. and Iida, S. and Nakajima, N. and Suzuki, T. and Yoshida, S. and Nobori, H. and Sanaki, T. and Kato, T. and Shishido, T. and Hall, W. W. and Orba, Y. and Sato, A. and Sawa, H.},
  year = {2022},
  doi = {10.1101/2022.02.14.480338},
  url = {https://www.biorxiv.org/content/10.1101/2022.02.14.480338v1},
  note = {Source identifier: 10.1101/2022.02.14.480338}
}